Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

CD200 Is a Stem Cell-Specific Immunosuppressive Target in AML

Shelley Herbrich, MS, Keith Baggerly, PhD, Gheath Alatrash, DO, PhD, R. Eric Davis, MD, Michael Andreeff, MD PhD, Marina Y. Konopleva, MD PhD

Blood (2018) 132 (Supplement 1): 2768.

https://doi.org/10.1182/blood-2018-99-114818

Published: 2018

Journal Articles

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Shelley Herbrich, MS, Peter P. Ruvolo, PhD, Vivian Ruvolo, PhD, Keith Baggerly, PhD, Gheath Alatrash, DO, PhD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD

Blood (2017) 130 (Supplement 1): 3962.

https://doi.org/10.1182/blood.V130.Suppl_1.3962.3962

Published: 2017

Journal Articles

Proteomic Profiling Identifies c-KIT and 53BP1 As Resistance Factors of AML Relapse Post Allogeneic Stem Cell Transplantation with G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning

Zhihong Zeng, MD, Hongbo Lu, MD, Rui-Yu Wang, MD, Wenbin Lu, PhD, Julianne Chen, Christopher B Benton, MD, Keith Baggerly, PhD, Elizabeth J Shpall, MD, Richard E Champlin, MD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD

Blood (2017) 130 (Supplement 1): 2528.

https://doi.org/10.1182/blood.V130.Suppl_1.2528.2528

Published: 2017

Journal Articles

Mapping Microenvironment-Mediated Signaling Dependency of Targeted Inhibitors: A Mechanism-Based Approach of Selecting Effective Therapy Targeting Drug Resistant AML

Zhihong Zeng, MD, Wenbin Liu, PhD, Twee Tsao, MS, Yihua Qiu, MD, Ismael Samudio, PhD, Keith Baggerly, PhD, Steven M. Kornblau, MD, Hagop M Kantarjian, MD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD

Blood (2015) 126 (23): 1398.

https://doi.org/10.1182/blood.V126.23.1398.1398

Published: 2015

Journal Articles

Targeting mTORC1/2 by a mTOR Kinase Inhibitor (PP242) induces Apoptosis In AML Cells Under Conditions Mimicking Bone Marrow Microenvironment

Zhihong Zeng, Yuexi Shi, Twee Tsao, Yihua Qiu, Steven M. Kornblau, MD, Keith Baggerly, Wenbin Liu, Yi Liu, PhD, Christian Rommel, PhD, David A. Fruman, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD

Blood (2010) 116 (21): 778.

https://doi.org/10.1182/blood.V116.21.778.778

Published: 2010

NARROW

CD200 Is a Stem Cell-Specific Immunosuppressive Target in AML

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Proteomic Profiling Identifies c-KIT and 53BP1 As Resistance Factors of AML Relapse Post Allogeneic Stem Cell Transplantation with G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning

Mapping Microenvironment-Mediated Signaling Dependency of Targeted Inhibitors: A Mechanism-Based Approach of Selecting Effective Therapy Targeting Drug Resistant AML

Targeting mTORC1/2 by a mTOR Kinase Inhibitor (PP242) induces Apoptosis In AML Cells Under Conditions Mimicking Bone Marrow Microenvironment

Email alerts

ASH Publications

American Society of Hematology

CD200 Is a Stem Cell-Specific Immunosuppressive Target in AML

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Proteomic Profiling Identifies c-KIT and 53BP1 As Resistance Factors of AML Relapse Post Allogeneic Stem Cell Transplantation with G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning

Mapping Microenvironment-Mediated Signaling Dependency of Targeted Inhibitors: A Mechanism-Based Approach of Selecting Effective Therapy Targeting Drug Resistant AML

Targeting mTORC1/2 by a mTOR Kinase Inhibitor (PP242) induces Apoptosis In AML Cells Under Conditions Mimicking Bone Marrow Microenvironment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only